PATENT CLAIM ANALYSIS

Application Number: 16129696
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "04400A"]

Abstract:
Disclosed herein are molecules and pharmaceutical compositions that induce an insertion, deletion, duplication, or alteration in an incorrectly spliced mRNA transcript to induce exon skipping or exon inclusion. Also described herein include methods for treating a disease or disorder that comprises a molecule or a pharmaceutical composition that induces an insertion, deletion, duplication, or alteration in an incorrectly spliced mRNA transcript to induce exon skipping or exon inclusion.

Claim (Index 5):
The method of  claim 1 , wherein the polynucleic acid molecule induces skipping of exon 53.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 97.0
- Lexical Diversity: 1.94872
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16129694', '16128440', '15288415', '15619984', '12605276']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7486382182506776
- 35 USC 102 Novelty (BERT): 0.5256203271377238
- Combined Prediction Score: 0.7263364291393821
- Mean Citation Score: 296.0966400000001
- Max Citation Score: 325.94104
- Similarity Product: 220.2659119554949

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test